Shorter Radiation Courses Become Standard Care for Localized Prostate Cancer in New Guideline
A new ASTRO clinical guideline recommends moderately shortened radiation schedules for all risk groups of localized prostate cancer and establishes ...
A new ASTRO clinical guideline recommends moderately shortened radiation schedules for all risk groups of localized prostate cancer and establishes ...
A new study links the metabolic enzyme ECHS1 to hypoxia-responsive PGK1 crotonylation and malignant phenotypes in prostate cancer cell and ...
A retrospective study reports that hardware-free data-driven gating significantly increased SUV measurements, improved contrast-to-noise ratio and reduced image noise compared ...
Long-term PEACE-1 trial results show that adding abiraterone to ADT and docetaxel reduced the risk of death by 32 percent ...
In the first-in-human TheraPb phase 1 trial, the alpha-emitting radiopharmaceutical 212Pb-ADVC001 was well tolerated at doses of 60–200 MBq with ...
An analysis of United States registry and health system data shows low-risk prostate cancer is being diagnosed less often and, ...
A phase 3 PROTEUS substudy published in European Urology reports that perioperative apalutamide plus hormone therapy around radical prostatectomy improved ...
A retrospective analysis of 127 patients found that only 5 percent-level few exceeded 20 Gy cumulative kidney dose after lutetium-177 ...
Podophyllotoxin and atisine from Himalayan medicinal plants showed potent cytotoxicity against lung and prostate cancer cells and favourable predicted binding ...
A large integrated transcriptomic study shows that rising cancer stemness tracks prostate cancer progression, lineage plasticity, therapy resistance, and poor ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine